Status:
COMPLETED
Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
University of Lorraine
Métropole du Grand Nancy
Conditions:
Coronavirus Infection
Prevalence
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
In order to inform the public decision on the containment strategy and knowledge of the intensity of the epidemic during post-containment, estimates of the share of the population infected with the SA...
Detailed Description
In order to inform the public decision on the containment strategy and knowledge of the intensity of the epidemic during post-containment, estimates of the share of the population infected with the SA...
Eligibility Criteria
Inclusion
- Person who has received full information about the research organization and signed informed consent
- Person residing in the Grand Nancy Metropolitan area
- Person aged at least 5 years on 1 June 2020 and weighing more than 7 kg
Exclusion
- Children under 5 years of age at the time of collection
- Person referred to in Articles L1121-8 of the Public Health Code. A person of full age who is subject to a legal protection measure (guardianship, curatorship, legal protection).
- Adult person unable to give consent
- \- Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care pursuant to articles L. 3212-1 and L. 3213-1.
Key Trial Info
Start Date :
June 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 24 2020
Estimated Enrollment :
2006 Patients enrolled
Trial Details
Trial ID
NCT04448769
Start Date
June 26 2020
End Date
July 24 2020
Last Update
August 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chru Nancy
Vandœuvre-lès-Nancy, France, 54500